Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,994 | -29,337 | -13,059 | -30,740 | -19,510 |
| Depreciation Amortization | 436 | 362 | 180 | 232 | 81 |
| Accounts payable and accrued liabilities | 2,502 | 3,128 | 1,681 | 1,343 | 2,322 |
| Other Working Capital | 3,544 | 4,690 | 1,544 | 4,241 | 3,718 |
| Other Operating Activity | 167 | -1,226 | -683 | 3,189 | 804 |
| Operating Cash Flow | $-35,345 | $-22,383 | $-10,337 | $-21,734 | $-12,585 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,503 | 8,204 | 5,784 | -36,806 | -38,169 |
| Investing Cash Flow | $19,503 | $8,204 | $5,784 | $-36,806 | $-38,169 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 71,499 | 108 | 61 | 49,924 | 49,906 |
| Common Stock Repurchased | -95 | -95 | N/A | -274 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 36,663 | 36,663 |
| Financing Cash Flow | $71,404 | $13 | $61 | $86,314 | $86,569 |
| Beginning Cash Position | 27,978 | 27,978 | 27,978 | 204 | 204 |
| End Cash Position | 83,540 | 13,812 | 23,486 | 27,978 | 36,019 |
| Net Cash Flow | $55,562 | $-14,166 | $-4,492 | $27,773 | $35,815 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,345 | -22,383 | -10,337 | -21,734 | -12,585 |
| Free Cash Flow | -35,345 | -22,383 | -10,337 | -21,734 | -12,585 |